Manufacturers Life Insurance Company, The Puma Biotechnology, Inc. Transaction History

Manufacturers Life Insurance Company, The

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$2.92 - $5.83 $51,873 - $103,569	17,765 New	17,765 $57,000
Q3 2021 Nov 12, 2021	SELL	$6.63 - $9.39 $138,626 - $196,335	-20,909 Closed	0 $0
Q2 2021 Aug 12, 2021	BUY	$8.98 - $11.6 $8,800 - $11,368	980 Added 4.92%	20,909 $192,000
Q1 2021 May 03, 2021	BUY	$9.38 - $13.63 $4,417 - $6,419	471 Added 2.42%	19,929 $194,000
Q4 2020 Feb 12, 2021	BUY	$7.78 - $12.13 $3,905 - $6,089	502 Added 2.65%	19,458 $200,000
Q2 2020 Aug 10, 2020	SELL	$7.01 - $13.24 $11,706 - $22,110	-1,670 Reduced 8.1%	18,956 $194,000
Q1 2020 May 15, 2020	BUY	$6.28 - $14.57 $5,212 - $12,093	830 Added 4.19%	20,626 $174,000
Q4 2019 Feb 14, 2020	SELL	$6.5 - $10.73 $1,176 - $1,942	-181 Reduced 0.91%	19,796 $173,000
Q2 2019 Aug 14, 2019	BUY	$12.3 - $35.76 $7,835 - $22,779	637 Added 3.29%	19,977 $254,000
Q1 2019 May 13, 2019	BUY	$20.77 - $42.37 $401,691 - $819,435	19,340 New	19,340 $751,000
Q4 2018 Feb 14, 2019	SELL	$20.07 - $46.7 $384,721 - $895,192	-19,169 Closed	0 $0
Q3 2018 Nov 14, 2018	SELL	$41.2 - $59.85 $109,015 - $158,363	-2,646 Reduced 12.13%	19,169 $879,000
Q2 2018 Aug 14, 2018	SELL	$48.3 - $68.25 $4,926 - $6,961	-102 Reduced 0.47%	21,815 $1.29 Million
Q1 2018 May 15, 2018	SELL	$59.7 - $99.25 $7,880 - $13,101	-132 Reduced 0.6%	21,917 $1.49 Million
Q4 2017 Feb 08, 2018	BUY	$93.85 - $132.45 $6,194 - $8,741	66 Added 0.3%	22,049 $2.18 Million
Q3 2017 Nov 14, 2017	BUY	$72.0 - $119.75 $1.58 Million - $2.63 Million	21,983	21,983 $2.63 Million

102

29.1M

60.6K

16.3K

Ticker PBYI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,556,000
Market Cap $128M
Description
Puma Biotechnology, Inc., a biopharmaceutical company, focuses on the development and commercialization of products to enhance cancer care in the United States and internationally. The company's drug candidates include PB272 neratinib (oral) for the patients with early stage HER2-overexpressed/amplified breast cancer; PB272 (neratinib, oral) for...

Get notified when there are updates to the investment portfolio of Manufacturers Life Insurance Company, The, based on Form 13F filings with the SEC.

Stay updated on Manufacturers Life Insurance Company, The with notifications on news.